U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a new federal initiative to build a comprehensive autism data platform using Medicare and Medicaid records. Designed to study the causes of autism spectrum disorder (ASD), the platform will integrate claims data, electronic health records, and data from wearable health devices, according to the Department of Health and Human Services (HHS).
The National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services (CMS) will collaborate on the effort, which is part of a broader $50 million research initiative to investigate potential environmental and medical causes of autism. Kennedy stated the project aims to provide "honest answers families have waited far too long to hear," despite his controversial history promoting a debunked link between vaccines and autism.
HHS said the platform will help researchers analyze autism diagnoses, treatment outcomes, healthcare access disparities, and the financial impact on families. However, experts like Dr. Helen Tager-Flusberg of Boston University argue the focus does not directly address autism’s root causes. She also noted that an existing NIH autism database recently went offline without explanation, raising concerns about transparency.
The project has sparked privacy questions, as HHS has not confirmed whether the database will be anonymous or voluntary. Autism researcher Eric Rubenstein noted that Medicaid and Medicare data offer insights into health disparities but lack environmental exposure data, which Kennedy claims he will explore.
Autism rates have surged in recent years, with the CDC reporting 1 in 31 U.S. 8-year-olds diagnosed in 2022. While Kennedy aims to identify autism’s causes by September, scientists emphasize that autism likely stems from a complex mix of genetic and environmental factors. Critics warn against oversimplifying this ongoing scientific challenge.


FDA Names Permanent Drug and Biologics Center Chiefs
US Immigration Arrests Surge as Deportations Lag Behind
Judge Orders Trump to Restore White House Access for CNN, MS NOW and Politico
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
FCC Approves Foreign Investment in $110B Paramount-Warner Bros. Deal
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Australia Tightens Student Visa Rules, Targets Migration Cut by 2028
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Trump Administration Removes Confederate Memorial Criticism From Arlington Website
3 clinical-grade skincare creams you really shouldn’t buy online
China Reviews Broadcom Switch Use in State Data Centres
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds 



